| Old Articles: <Older 46791-46800 Newer> |
 |
The Motley Fool January 27, 2011 Brian Orelli |
Abbott Labs: Growth in All the Wrong Places Abbott's a solid company with solid dividend and growth potential in the near term. But investors need to be careful extrapolating that growth out.  |
The Motley Fool January 27, 2011 Dan Caplinger |
What Buyback Mania Means for You Don't jump into a stock solely because the company's buying back shares.  |
The Motley Fool January 27, 2011 Alyce Lomax |
Inflation Nips Starbucks in the Bean The coffee giant's rising costs will squeeze its customers, too.  |
The Motley Fool January 27, 2011 Michael Kanellos |
Cree Unfurls Its Household LED Bulb The price isn't out yet, but it cranks 800 lumens. Could it be the true 60 watt replacement?  |
The Motley Fool January 27, 2011 Brian Orelli |
Amylin Timeline Shortened -- Maybe Revenue down 6% year over year. Prescriptions of the company's top-selling drug, Byetta, down 5.9% quarter over quarter. Amylin Pharmaceuticals' fourth quarter wasn't pretty.  |
The Motley Fool January 27, 2011 Rick Aristotle Munarriz |
Did Netflix Just Surpass Sirius XM Radio? The video rental site and satellite radio service both reach 20 million subscribers.  |
The Motley Fool January 27, 2011 Adam J. Crawford |
Fuel Systems Shareholders Fall Victim to the D-Word Avoid dilution in your investments. Here's how.  |
The Motley Fool January 27, 2011 Travis Hoium |
An Unlikely Boost for Solar Stocks New Chinese regulations may save solar from itself.  |
The Motley Fool January 27, 2011 David Lee Smith |
Occidental Petroleum: Active and Attractive Occidental's quarterly results seemed more positive than the market's reaction indicated.  |
The Motley Fool January 27, 2011 Roger Friedman |
Help Amanda Make Her Next Pick Our fabulous front-desk investor seeks guidance on her next stock purchase.  |
| <Older 46791-46800 Newer> Return to current articles. |